Approval given to use Coronil as supporting measure in Covid management: MoS Health.

Coronil Kit which claims to be an effective immune booster against Covid- 19 by Patanjali Ayurved has been approved as a supporting measure in Covid management: MoS Health

Coronil Swasari Kit -(Coronil + Swasari + Anu Tail) which comes with a price of Rs. 545
For DIVYA SWASARI CORONIL KIT117 gm and Divya Swasari Coronil Kit CLD (24 Pcs)2.808 kg for Rs. 13080

Divya Coronil Tablet – Acts as a COVID-19 immunity booster agent. • Divya Swasari Vati – Helps treat symptoms like the common cold, cough, etc and had been tested on 100 people, all of whom were asymptomatic or had mild symptoms of COVID-19,” says Dr. Anurag Varshney

Hence Press trust of India in its press release said “The State Licensing Authority of Uttarakhand has granted the license for Coronil tablet to be used as supporting the measure in the management of COVID-19 without claiming cure following the advice of a review committee set up by the AYUSH ministry, the Lok Sabha was informed on Friday.

Minister of State for Health Bharati Pravin Pawar, in a written reply, said the Interdisciplinary Technical Review Committee (ITRC) set up by the AYUSH ministry reviewed the application submitted by the Patanjali Research Foundation Trust for updating the AYUSH license for Divya Coronil tablet from immunity booster’ to medicine for COVID-19′.

The application titled Updating AYUSH license for Divya Coronil tablet from Immunity booster to Medicine for COVID-19′ submitted by Patanjali Research Foundation Trust, Haridwar, Uttarakhand to this Ministry, was placed before the ITRC on October 27, 2020, for examination of the applications/claims on patent and propriety (P&P) ASU&H medicines with new indications or repurposing of licensed P&P, ASU&H medicines for COVID-19, Pawar said in her reply.

Explaining the rules under which such approval was granted, Pawar said the regulatory provisions for granting license and approval of Ayurvedic, Siddha, Unani, and Homeopathy drugs are prescribed under the Drugs and Cosmetics Act, 1940 and Rules 1945.

Section 3(a) and Section 3(h) define all Ayurvedic, Siddha, Unani medicines intended for internal or external use for or in the diagnosis, treatment, mitigation, or prevention of diseases or disorders in human beings or animals, and manufactured exclusively in accordance with the formulae described in, the authoritative books of Ayurvedic, Siddha and Unani Tibb systems of medicine, specified in the First Schedule.

“The State Licensing Authority Uttarakhand has granted the license of drug Coronil after examination of the application submitted by the applicant. The State Licensing Authority Ayurveda, Government of Uttarakhand was informed that Coronil tablet may be used as supporting the measure in the management of COVID-19 without claiming cure,” the minister added”.

Ravi Tilekar

Published by
Ravi Tilekar

Recent Posts

Cars24 raised $450 million in a Series F round of funding.

Cars24, an e-commerce platform for used vehicles which became a unicorn last year in its…

20 hours ago

ePayLater, a fintech startup, has raised $10 million in a recent round of funding.

Fintech startup ePaylater has raised $10 from its investors which includes Zurich-based Responsibility Investments AG,…

2 days ago

Ippo Pay has raised $250,000 in pre-seed funding from early-stage investor.

IppoPay has raised $250,000 of the estimated amount from an early-stage investor, Better Capital, along…

4 days ago

Asian Merchant commerce giant Pine labs raised another $100 million, readying to file an IPO.

The company was valued at $3.5 billion after it raised around $600 million in its…

5 days ago

“Apna” The fastest domestic startup to reach Unicorn Club.

There was a buzz of making Apna app the fastest domestic startup to reach unicorn…

5 days ago

Shobitam: Democratizing Ethnic Fashion Globally.

Shobitam is a startup based in Bangalore and Seattle, with a big bold vision to…

1 week ago